findmyKOL

Surya Bhatt, MD

Enriched profile

Professor of Medicine (Endowed Professorship in Airways Disease), Division of Pulmonary, Allergy and Critical Care Medicine · University of Alabama at Birmingham

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Bethlehem, PA · Northeast · United StatesSpecialtyPulmonary DiseaseFocusChronic Obstructive Pulmonary Disease (COPD) Research+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Surya Bhatt is Professor of Medicine (Endowed Professorship in Airways Disease), Division of Pulmonary, Allergy and Critical Care Medicine at University of Alabama at Birmingham. OpenAlex indexes 525 publications with 12,437 citations (h-index 56); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 25 Aug 2026

Overview

Updated 14 Oct 2026

Surya Bhatt, MD, is Professor of Medicine (Endowed Professorship in Airways Disease), Division of Pulmonary, Allergy and Critical Care Medicine at University of Alabama at Birmingham. The public record shows 525 publications with 12,437 citations (h-index 56), centered on Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Asthma and respiratory diseases. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 23 companies.

  • Most recent indexed publication: 2026 · Annals of the American Thoracic Society
  • Top research focus: Chronic Obstructive Pulmonary Disease (COPD) Research
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 23 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
COPD5 trialsLung Diseases5 trialsAsthma1 trialEmphysema1 trialPulmonary Hypertension

Research focus

OpenAlex concept fingerprint
Chronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and MechanismsAsthma and respiratory diseasesInhalation and Respiratory Drug DeliveryPulmonary Hypertension Research and Treatments

Drugs & molecules

across trials, industry payments and publications
Dupixentgeneric · DupilumabClinical trials—Industry payments111Publications2Breztrigeneric · Budesonide / formoterol / glycopyrroniumClinical trials—Industry payments11Publications—Fasenrageneric · BenralizumabClinical trials—Industry payments10Publications—Stiolto RespimatClinical trials—Industry payments8Publications—XenonClinical trials—Industry payments7Publications—Yupelrigeneric · RevefenacinClinical trials—Industry payments7Publications—Nucalageneric · MepolizumabClinical trials—Industry payments2Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments1Publications—Ohtuvayregeneric · EnsifentrineClinical trials—Industry payments1Publications—Saphnelogeneric · AnifrolumabClinical trials—Industry payments1Publications—Spirivageneric · TiotropiumClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials1Industry payments2Genzyme CorporationClinical trials—Industry payments110AstraZeneca Pharmaceuticals LPClinical trials—Industry payments32Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments30Genentech USA, Inc.Clinical trials—Industry payments15Merck Sharp & Dohme LLCClinical trials—Industry payments15Sanofi-Aventis U.S. LLCClinical trials—Industry payments15GlaxoSmithKline, LLC.Clinical trials—Industry payments13Chiesi USA, Inc.Clinical trials—Industry payments12AstraZeneca UK LimitedClinical trials—Industry payments11F. Hoffmann-La Roche AGClinical trials—Industry payments11Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments9Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments9Sanofi Us Services Inc.Clinical trials—Industry payments9Polarean, Inc.Clinical trials—Industry payments7Boehringer Ingelheim International GmbHClinical trials—Industry payments5Mylan Specialty L.P.Clinical trials—Industry payments4University of Alabama at BirminghamClinical trials4Industry payments—Mylan Inc.Clinical trials—Industry payments3Pulmonx CorporationClinical trials—Industry payments2Aero US IncClinical trials—Industry payments1Apreo Health, Inc.Clinical trials1Industry payments—Nuvaira, Inc.Clinical trials1Industry payments—Roche Products LimitedClinical trials—Industry payments1Sanofi Pasteur Inc.Clinical trials—Industry payments1Verona Pharma, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
525publications

Distinct works indexed by OpenAlex, matched via ORCID; 75 in PubMed.

12,437citations

Total citations across indexed works.

56h-index

Hirsch index (OpenAlex). i10-index 205.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
23companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    34.5%
    Corticosteroid21.8%
    Trelegy Ellipta100%
    Part D<11 patients
    beta2-Adrenergic Agonist12.6%
    Albuterol Sulfate Hfa100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    29.9%
    Corticosteroid29.9%
    Prednisone100%
    Part D<11 patients
  • Anti-infectives

    23%
    Macrolide Antimicrobial23%
    Azithromycin100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Mark T. Dransfield143MeiLan K. Han97Sandeep Bodduluri83J. Michael Wells77Eric A. Hoffman73Jeffrey L. Curtis63Edwin K. Silverman59Gerard J. Criner58George R. Washko56Russell P. Bowler55Igor Barjaktarević53James D. Crapo53Nicola A. Hanania51Barry J. Make50Alejandro P. Comellas49Richard Casaburi48David Couper48Gregory L. Kinney47Arie Nakhmani47Fernando J. Martínez47Joseph M. Reinhardt46Nadia N. Hansel45R. Graham Barr45Prescott G. Woodruff43Elizabeth A. Regan42Frank C. Sciurba41David A. Lynch40Hrudaya Nath39Robert A. Wise39Wassim W. Labaki39Marilyn G. Foreman39Raúl San Jośe Estépar38Dawn L. DeMeo38Alejandro A. Díaz37Nirupama Putcha37John E. Hokanson36Robert Paine36Carla G. Wilson35John D. Newell34Spyridon Fortis34

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/surya-bhatt-7ba14810

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • X / Twitter

    x.com/suryapbhatt

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/UABHeersink/posts/surya-bhatt-md-in-the-uab-division-of-pulmonary-allergy-and-critical-care-medici/6088089254585291

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
  • X / Twitter

    twitter.com/UABPulmonary

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →twitter.com ↗
  • X / Twitter

    X (Twitter): @suryapbhatt

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Medical Director

    UAB Pulmonary Function and Exercise Physiology Laboratory

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu ↗
  • Medical Director

    UAB Telehealth Pulmonary Rehabilitation Program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu ↗
  • Director

    UAB Lung Imaging Core (Center for Lung Analytics and Imaging Research)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uab.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.